Balistreri, 1985 - Google Patents
Neonatal cholestasisBalistreri, 1985
- Document ID
- 2364103374201655732
- Author
- Balistreri W
- Publication year
- Publication venue
- The Journal of pediatrics
External Links
Snippet
THE HETEROGENEOUS NATURE of the diseases that have neonatal cholestasis (prOlonged conjugated hyperbilirubinemia) as the initial manifestation creates challenges in evaluation and in effective management. The list of potential causes of cholestasis in early …
- 206010056528 Neonatal cholestasis 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Balistreri | Neonatal cholestasis | |
| Hofmann | Bile acid malabsorption caused by ileal resection | |
| Rescorla et al. | Contemporary management of meconium ileus | |
| Venigalla et al. | Neonatal cholestasis | |
| Suchy | Neonatal cholestasis | |
| Ohi | Biliary atresia: a surgical perspective | |
| Losowsky et al. | Liver disease and malabsorption | |
| Kopel | Gastrointestinal manifestations of cystic fibrosis | |
| Srivastava et al. | Urolithiasis in adolescent children | |
| Hamilton et al. | Short small intestine associated with malrotation: a newly described congenital cause of intestinal malabsorption | |
| Isenberg | Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism | |
| Farrell et al. | Parenteral nutrition and hepatobiliary dysfunction | |
| Kim et al. | Necrotizing enterocolitis | |
| Di Dato et al. | IFALD in children: What's new? A narrative review | |
| Fitzgerald | Cholestatic disorders of infancy | |
| McKiernan | The infant with prolonged jaundice: investigation and management | |
| Hartley | The jaundiced baby | |
| Macdonald et al. | Meconium ileus: an eleven-year review at the Hospital for Sick Children, Toronto | |
| Gartner et al. | Disorders of bilirubin metabolism | |
| Garcia et al. | Nonpulmonary manifestations of cystic fibrosis | |
| Amoury | Necrotizing enterocolitis: a continuing problem in the neonate | |
| Rosenthal et al. | Jaundice in infancy | |
| Zimber et al. | Effects of lithocholic acid exposure throughout pregnancy on late prenatal and early postnatal development in rats | |
| Borowitz | Pathophysiology of gastrointestinal complications of cystic fibrosis | |
| Figueroa-Colon et al. | Gallbladder sludge and lithiasis in an infant born to a morphine user mother |